The company's September quarter revenue surged 122% to ₹187.86 crore, while consolidated net profit more than doubled to ₹56.22 crore. Domestic operations generated 67% of first-half sales, heavily supported by the fast-moving consumer goods segment alongside steady global institutional demand. Additionally, a retail partnership with Style Baazar is projected to contribute roughly ₹200 crore during the current financial year. Following these robust results, full-year FY27 forecasts were revised upward to at least ₹880 crore in revenue and ₹275 crore in net profit.
Key points
Management upgraded its FY27 guidance to target a minimum of ₹880 crore in revenue and ₹2…: Management upgraded its FY27 guidance to target a minimum of ₹880 crore in revenue and ₹275 crore in net profit.
Expanded retail distribution partnerships with V2 Retail and Style Baazar are strengtheni…: Expanded retail distribution partnerships with V2 Retail and Style Baazar are strengthening the domestic consumer healthcare footprint.
Long-term corporate projections anticipate revenue surpassing ₹1,305 crore in FY28 and ex…: Long-term corporate projections anticipate revenue surpassing ₹1,305 crore in FY28 and exceeding ₹1,950 crore in FY29.
Sources checked by our analysis pipeline: 1
Cupid share price surged 10% to touch all-time high of ₹389 apiece on the BSE, on Thursday, 12 November, after the company reported a strong set of Q2 FY27 results, driven by robust growth in its domestic consumer healthcare and FMCG operations, along with steady demand in international markets.
The company’s consolidated net profit more than doubled to ₹56.22 crore in the September quarter, marking a 133% year-on-year increase from ₹24.13 crore in Q2 FY26. Revenue from operations climbed 122% to ₹187.86 crore.
For the first half of FY27, Cupid’s net profit rose 156% year-on-year to ₹100.37 crore, compared with ₹39.14 crore in the corresponding period last year. Revenue increased 137% to ₹342.58 crore.
EBITDA for H1 FY27 stood at ₹114.83 crore, up 156% from a year earlier. In Q2, EBITDA came in at ₹54.77 crore, with an operating margin of 29%.
A key contributor to Cupid’s performance was the expanding share of its domestic consumer healthcare and FMCG operations. The domestic business generated ₹224.64 crore in H1 FY27, accounting for 67% of total sales, compared with 41% in FY26.
Investors are monitoring market movements as shares face downward pressure during the current session. The sudden dip highlights ongoing fluctuations in the technology sector as trading progresses. Analysts continue to watch trading volumes to assess the broader impact on the company's valuation.
Market participants observed significant upward momentum in the company's valuation during today's trading session. The notable surge propelled the asset into unprecedented territory despite broader economic variables. Investors continue monitoring the environment to gauge how long these elevated price levels can be sustained.
Shares of Life Insurance of India are climbing today. Specific details and market factors driving the upward movement in the stock have not been released. Further information regarding the company's performance remains unavailable at this time.